Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Fish and Richardson
Covington
Baxter
Chinese Patent Office
Queensland Health
AstraZeneca
McKesson

Generated: September 24, 2018

DrugPatentWatch Database Preview

Erythromycin estolate - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin estolate and what is the scope of erythromycin estolate patent protection?

Erythromycin estolate is the generic ingredient in three branded drugs marketed by Barr, Ivax Sub Teva Pharms, Watson Labs, Lilly, Dista, Alpharma Us Pharms, G And W Labs Inc, and Life Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and two drug master file entries for erythromycin estolate.

Summary for erythromycin estolate
US Patents:0
Tradenames:3
Applicants:8
NDAs:14
Drug Master File Entries: 102
Bulk Api Vendors: 33
Patent Applications: 2,187
DailyMed Link:erythromycin estolate at DailyMed
Medical Subject Heading (MeSH) Categories for erythromycin estolate
Synonyms for erythromycin estolate
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-2-O-propanoyl-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13
[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy
[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-4-[(2S,4S,5R,6R)-4-methoxy-4,6-dimethyl-5-oxidanyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-7,12,13-tris(oxidanyl)-2,10-bis(oxidanylidene)-1-oxacycl
[4-(dimethylamino)-2-[[(3R,4S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahyd
[4-(dimethylamino)-2-[[(3R,4S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate
[4-(dimethylamino)-2-[[14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate; dodecyl hydrogen sulfate
12167-63-4
14-Ethyl-7,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-6-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]oxacyclotetradec-4-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranoside
28375-06-6
31261-46-8
3521-62-8
521E628
A822654
AB1009508
AC1L2DBU
AC1L8NYG
AC1L9B1V
AKOS015896121
AKOS015951397
BDBM31688
Biomicron
C-23603
C08031
C40H71NO14.C12H26O4S
C40H71NO14.C12H26SO4
CA009565
CAS-3521-62-8
CC-27518
CCG-38968
CHEBI:4846
CHEMBL2218877
D00851
DR003673
DSSTox_CID_17224
DSSTox_GSID_37224
DSSTox_RID_79309
DTXSID1037224
EINECS 222-532-4
Eriscel
Eritroger
Eromycin
Ery-Toxinal dodecylsulfate
Erythromycin 2'-propanoate dodecyl sulfate (salt)
Erythromycin 2'-propanoate Dodecyl Sulfate Salt
Erythromycin 2'-propionate dodecyl sulfate (salt)
Erythromycin 2'-propionate monododecyl sulfate (salt)
Erythromycin 2''-propionate dodecyl sulfate
Erythromycin 5-(3-propionate) dodecyl sulfate
Erythromycin estolate (USP)
Erythromycin estolate [USAN:BAN:JAN]
Erythromycin estolate [USAN:USP:BAN:JAN]
Erythromycin estorate
Erythromycin estorate (JAN)
ERYTHROMYCIN LAURYL SULFATE, PROPIONYL
Erythromycin propionate (ester) compd. with monododecyl sulfate (1:1)
Erythromycin propionate compd. with dodecyl sulfate
Erythromycin propionate compound with dodecyl sulfate
Erythromycin Propionate Dodecyl Sulfate
Erythromycin propionate dodecylsulfate (salt)
erythromycin propionate lauryl sulfate
Erythromycin Propionate Monododecyl Sulfate
Erythromycin propionate, compd. with dodecyl sulfate
Erythromycin propionate, compound with dodecyl sulfate
Erythromycin propionyl laurylsulfate
Erythromycin, 2'-propanoate, dodecyl sulfate (salt)
Erythromycin, 2'-propionate, monododecyl sulfate (salt)
Erythromycin, 2'-propionate, monododecyl sulfate (salt) (8CI)
Erythromycin, compd. with monododecyl sulfate (1:1)
Erythromycin, dodecyl sulfate (salt)
Erythromycin, monododecyl sulfate (salt)
Erythromycin, propionate (ester), compd. with monododecyl sulfate
Erythromycin, propionate (ester), compd. with monododecyl sulfate (1:1)
Erythromycine estolate
Erytrarco
Estomicina
H892
HMS1921N13
HMS2092J15
HMS500A11
I06-1630
Ilosone
Lauromicina
Lauryl sulfate propionyl erythromycin ester
LMPK04000015
LS-64690
Lubomycine B
Marcoeritrex
MolPort-003-666-883
MolPort-003-847-089
monopropionylerythromycin laurylsulfate
NCGC00180881-01
NCGC00255571-01
Neo-erycinum
NSC 263364
NSC-263364
NSC-757880
NSC263364
NSC757880
PELS
Pharmakon1600-01501176
propanoic acid [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotet
propionic acid, 2'-ester with erythromycin, dodecyl sulfate
Propionic acid, 2'-ester with erythromycin, dodecyl sulfate salt
PROPIONYL ERYTHROMYCIN LAURYL SULFATE
Propionylerythromycin lauryl sulfate
Prospiocine
Q-201066
Roxomicina
SCHEMBL3331
SPECTRUM1501176
Stellamicina
Sulfuric acid monododecyl ester compd. with erythromycin 2'-propionate (1:1)
Sulfuric acid, compd. with erythromycin propionate
Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propanoate (1:1)
Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propionate (1:1)
Tox21_302229
UNII-XRJ2P631HP
VA10835
WLN: V2
XRJ2P631HP

US Patents and Regulatory Information for erythromycin estolate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062409-001 Dec 16, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ILOSONE erythromycin estolate SUSPENSION/DROPS;ORAL 061894-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 061894-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Fish and Richardson
Covington
Baxter
Chinese Patent Office
Queensland Health
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.